Fate Therapeutics Inc.

FATE | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.60

+$0.07 (+2.77%)

Sep 22, 2026, 11:19 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-136.32M	-186.26M	-160.93M	-281.72M	-212.15M	-173.39M
Depreciation & Amortization	9.3M	18.96M	18.28M	13.76M	5.85M	3.09M
Stock-Based Compensation	24.92M	41.5M	43.46M	78.73M	54.36M	30.75M
Other Working Capital	2.66M	816K	11.47M	-19.16M	5.26M	-5.7M
Other Non-Cash Items	-247K	4.89M	-52.26M	-24.27M	-13.03M	113.09M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.74M	-1.96M	19.18M	-34.71M	2.1M	-12.77M
Operating Cash Flow	-106.08M	-122.87M	-132.26M	-248.21M	-162.87M	-39.23M
Capital Expenditures	-5.95M	-730K	-6.15M	-35.57M	-50.7M	-4.93M
Cash Acquisitions	362K	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-195.14M	-317.75M	-358.81M	-404.8M	-968.16M	-277.34M
Sales Maturities Of Investments	311.9M	330.7M	477.63M	607.11M	694.84M	121.2M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	111.17M	12.22M	112.67M	166.75M	-324.02M	-161.08M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.49M	5.07M	n/a	n/a	41.39M	490K
Financial Cash Flow	5.49M	99.89M	85K	9.21M	453.13M	282.84M
Net Cash Flow	10.57M	-5.81M	-19.46M	-72.25M	-33.76M	67.53M
Free Cash Flow	-112.04M	-123.6M	-138.42M	-283.77M	-213.57M	-44.16M
Adj. Free Cash Flow	-136.96M	-165.1M	-181.88M	-362.51M	-267.94M	-74.91M
Maintenance CapEx	-5.95M	-730K	-6.15M	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	-35.57M	-50.7M	-4.93M
Owner Earnings	-112.04M	-123.6M	-138.42M	-248.21M	-162.87M	-39.23M